MedPath

A Multicenter Phase II/III, Placebo-Controlled Study of SNX-111 Administered Intrathecally to Cancer and AIDS Patients With Chronic Pain

Phase 2
Completed
Conditions
HIV Infections
Cancer
Pain
Registration Number
NCT00002160
Lead Sponsor
Neurex
Brief Summary

To determine the safety and efficacy of SNX-111 in controlling severe, chronic pain in cancer and AIDS patients.

Detailed Description

Patients are randomized to receive SNX-111 or placebo (AS PER AMENDMENT 1/22/98: with randomization weighted 2:1 in favor of SNX-111) via external pump and an intrathecal catheter (thin tube inserted into the spinal canal). (AS PER AMENDMENT 1/22/98: the dose is increased every 24 hours, in the absence of onset of analgesia or adverse events. After 2-5 days, patients who respond to their medication continue treatment at home for 5-8 days. Patients who do not respond will be switched to the other regimen (i.e., placebo to SNX-111, or SNX-111 to placebo). After 10 days, responding patients are unblinded and asked to enroll in the long-term, open-label extension protocol. Patients remain on a fixed dose at the therapeutic level found in the previous study. The dose may be increased or decreased at the discretion of the investigator. Patients may continue therapy on a long-term basis until the drug is approved.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (44)

Emory Univ Hosp

🇺🇸

Atlanta, Georgia, United States

Cleveland Clinic Foundation

🇺🇸

Cleveland, Ohio, United States

Thomas Jefferson Univ Hosp

🇺🇸

Philadelphia, Pennsylvania, United States

Swedish Pain Management

🇺🇸

Seattle, Washington, United States

Northwest Neuroscience Institute

🇺🇸

Seattle, Washington, United States

Northport Hosp

🇺🇸

Northport, Alabama, United States

VA Med Ctr / Oncology Section

🇺🇸

Washington, District of Columbia, United States

Univ of CA - San Diego

🇺🇸

San Diego, California, United States

Neurosurgical Associates

🇺🇸

Terre Haute, Indiana, United States

Long Island Pain Management

🇺🇸

Port Jefferson Station, New York, United States

Elkhardt Gen Hosp

🇺🇸

Elkhardt, Indiana, United States

Connecticut Pain Care

🇺🇸

Danbury, Connecticut, United States

Univ of Missouri Med Ctr

🇺🇸

Columbia, Missouri, United States

H Lee Moffit Cancer Ctr and Research Institute

🇺🇸

Tampa, Florida, United States

Holt Krock Clinic

🇺🇸

Fort Smith, Arkansas, United States

Johns Hopkins Hosp

🇺🇸

Baltimore, Maryland, United States

Pain Management

🇺🇸

New York, New York, United States

Brigham and Women's Hosp

🇺🇸

Boston, Massachusetts, United States

Pain Diagnosis and Treatment

🇺🇸

Glendora, California, United States

Minneapolis Veterans Administration

🇺🇸

Minneapolis, Minnesota, United States

Good Samaritan Hosp Ctr

🇺🇸

San Jose, California, United States

Cook County Hosp

🇺🇸

Chicago, Illinois, United States

Cooper Hospital Early Intervention Program

🇺🇸

Camden, New Jersey, United States

Marschfield Clinic

🇺🇸

Marshfield, Wisconsin, United States

Pennsylvania State College of Medicine

🇺🇸

Hershey, Pennsylvania, United States

Univ of Kansas Med Ctr

🇺🇸

Kansas City, Kansas, United States

Gulf Coast Clinical Services

🇺🇸

Mobile, Alabama, United States

The Pain Institute

🇺🇸

Kansas City, Missouri, United States

Pain Control Ctr

🇺🇸

Chicago, Illinois, United States

Bowman Gray School of Medicine / Wake Forest Univ

🇺🇸

Winston Salem, North Carolina, United States

Lehigh Valley Hosp

🇺🇸

Allentown, Pennsylvania, United States

Univ of Miami School of Medicine

🇺🇸

Miami, Florida, United States

Alta Bates Hosp

🇺🇸

Berkeley, California, United States

Ctr for Pain Management and Rehabilitation

🇺🇸

Huntsville, Alabama, United States

Univ of Iowa Hosp

🇺🇸

Iowa City, Iowa, United States

Univ of Rochester

🇺🇸

Rochester, New York, United States

Methodist Hosp

🇺🇸

Memphis, Tennessee, United States

Texas Tech Univ Health Science Ctr

🇺🇸

Lubbock, Texas, United States

Fairfax Hosp

🇺🇸

Falls Church, Virginia, United States

Univ of Texas Health Sciences Ctr

🇺🇸

San Antonio, Texas, United States

Clinical Solutions

🇺🇸

Princeton, New Jersey, United States

Louisiana State Univ

🇺🇸

Shreveport, Louisiana, United States

Univ of Tennessee

🇺🇸

Memphis, Tennessee, United States

New Orleans Pharmaceutical Research

🇺🇸

Kenner, Louisiana, United States

© Copyright 2025. All Rights Reserved by MedPath